Nexgel (NXGLW) Other Non-Current Liabilities (2018 - 2024)
Nexgel's (NXGLW) quarterly Other Non-Current Liabilities came in at $178000.0 in Q4 2024, down 59.45% YoY from $439000.0 in Q1 2024, and down 34.32% on a QoQ basis from $271000.0 in Q3 2024.
Nexgel (NXGLW) Other Non-Current Liabilities (2018 - 2024) Analysis & Trends
Nexgel (NXGLW) has 3 years of Other Non-Current Liabilities data on file, last reported at $178000.0 in Q4 2024.
- Quarterly Other Non-Current Liabilities fell 59.45% year-over-year to $178000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $178000.0 (down 59.45% YoY) and the FY2024 annual result came in at $178000.0, down 59.45% from the prior year.
- Other Non-Current Liabilities slipped to $178000.0 in Q4 2024, from $271000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $439000.0 in Q4 2023 to a low of $178000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 271,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Mar 31, 2024 | 439,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Dec 31, 2018 | 51,000.00 |